GeneDx Holdings Corp - Warrant — Cash Flow (NASDAQ:WGSWW) | MetaTrader

Open full chart

Financials

Overview Relatórios Statistics Dividends

Quarterly Annual

Cash from operating activities —190.43 M319.15 M180.15 M28.5 M33.28 M 33.28 M Cash from investing activities —20.79 M141.33 M43.73 M30.13 M61.52 M 61.52 M Cash from financing activities —493.73 M197.31 M186.24 M44.16 M48.02 M 48.02 M Free cash flow —169.65 M304.83 M174.44 M23 M14.26 M 14.26 M

Notícias

GeneDx: Fundamentals Intact Though Q4 Results Pause Near Term Momentum

GeneDx: A Moment Of Reckoning As Market Awaits Q3 Testing Growth (NASDAQ:WGS)

GeneDx Holdings Corp. 2025 Q2 - Results - Earnings Call Presentation (NASDAQ:WGS)

GeneDx Holdings Corp. (WGS) Q2 2025 Earnings Call Transcript

Macquarie Small Cap Growth Fund Q1 2025 Commentary (WGSWW)

Harbor Health Care ETF Q1 2025 Commentary (undefined:MEDI)

Invesco Health Care Fund Q4 2024 Commentary

GeneDx: Exome Testing And EPIC Aura Integration Make It A GARP 'Buy' (NASDAQ:WGS)

GeneDx Holdings Corp. (WGS) Q4 2024 Earnings Call Transcript